The E. coli lite strains: new expression strains for the production of toxic membrane proteins.
The production of recombinant biopharmaceuticals is a billion-dollar industry, with numerous high-value proteins expressed in the bacterium Escherichia coli. Many recombinant protein production (RPP) systems enable the synthesis and purification of large amounts of soluble recombinant protein. However, such systems are...